Semaglutide vs Tirzepatide
Community comparisons of semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) — switching, stacking, and head-to-head GLP-1 experiences.
3 anonymous reports
We're collecting more reports on this topic.
Submit yourscommunity guides:
related topics:
Community Q&A
- What is the difference between semaglutide and tirzepatide?
- Semaglutide activates GLP-1 receptors only. Tirzepatide adds GIP receptor activation — a dual mechanism community accounts frequently describe as producing stronger weight loss with a different side effect profile. The most consistent theme in comparison confessions: tirzepatide causes less nausea for users who struggled on semaglutide, while producing greater total weight loss at equivalent dose stages.
- Is tirzepatide better than semaglutide for weight loss?
- Community accounts that compare both compounds favour tirzepatide for total weight loss, with many describing a 5–10 lb advantage over the same timeline. A subset of reports describe better tolerability on semaglutide, particularly those sensitive to GIP-related side effects. Both produce meaningful results — the switching accounts lean tirzepatide, but the tolerability accounts are split.
- What happens when you switch from semaglutide to tirzepatide?
- Switching accounts describe a transition period of 2–4 weeks where the new drug 'takes over.' Most describe improved weight loss momentum after the switch. A recurring theme: starting tirzepatide at a lower dose than the semaglutide dose being discontinued, then escalating. Accounts that switch without a tapering period describe more side effects in the transition weeks.